Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor

被引:238
作者
Huang, WD
Zhang, J
Washington, M
Liu, J
Parant, JM
Lozano, G
Moore, DD [1 ]
机构
[1] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA
关键词
D O I
10.1210/me.2004-0520
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The constitutive androstane receptor (CAR, NR1I3) is a central regulator of xenobiotic metabolism. CAR activation induces hepatic expression of detoxification enzymes and transporters and increases liver size. Here we show that CAR-mediated hepatomegaly is a transient, adaptive response to acute xenobiotic stress. In contrast, chronic CAR activation results in hepatocarcinogenesis. In both acute and chronic xenobiotic responses, hepatocyte DNA replication is increased and apoptosis is decreased. These effects are absent in CAR null mice, which are completely resistant to tumorigenic effects of chronic xenobiotic stress. In the acute response, direct up-regulation of Mdm2 expression by CAR contributes to both increased DNA replication and inhibition of p53-mediated apoptosis. These results demonstrate an essential role for CAR in regulating both liver homeostasis and tumorigenesis in response to xenobiotic stresses, and they also identify a specific molecular mechanism linking chronic environmental stress and tumor formation.
引用
收藏
页码:1646 / 1653
页数:8
相关论文
共 43 条
  • [1] Inhibition of apoptosis in rat hepatocytes treated with 'non-dioxin-like' polychlorinated biphenyls
    Bohnenberger, S
    Wagner, B
    Schmitz, HJ
    Schrenk, D
    [J]. CARCINOGENESIS, 2001, 22 (10) : 1601 - 1606
  • [2] Focus on hepatocellular carcinoma
    Bruix, J
    Boix, L
    Sala, M
    Llovet, JM
    [J]. CANCER CELL, 2004, 5 (03) : 215 - 219
  • [3] CONTROLLED DEATH (APOPTOSIS) OF NORMAL AND PUTATIVE PRENEOPLASTIC CELLS IN RAT-LIVER FOLLOWING WITHDRAWAL OF TUMOR PROMOTERS
    BURSCH, W
    LAUER, B
    TIMMERMANNTROSIENER, I
    BARTHEL, G
    SCHUPPLER, J
    SCHULTEHERMANN, R
    [J]. CARCINOGENESIS, 1984, 5 (04) : 453 - 458
  • [4] Christensen JG, 1999, MOL CARCINOGEN, V25, P273
  • [5] MDM2: life without p53
    Daujat, S
    Neel, H
    Piette, J
    [J]. TRENDS IN GENETICS, 2001, 17 (08) : 459 - 464
  • [6] TUMOR-PROMOTING AND HEPATOCARCINOGENIC EFFECTS OF 1,4-BIS[2-(3,5-DICHLOROPYRIDYLOXY)]BENZENE (TCPOBOP) IN DBA/2NCR AND 2C57BL/6NCR MICE AND AN APPARENT PROMOTING EFFECT ON NASAL CAVITY TUMORS BUT NOT ON HEPATOCELLULAR TUMORS IN F344/NCR RATS INITIATED WITH N-NITROSODIETHYLAMINE
    DIWAN, BA
    LUBET, RA
    WARD, JM
    HRABIE, JA
    RICE, JM
    [J]. CARCINOGENESIS, 1992, 13 (10) : 1893 - 1901
  • [7] Farazi PA, 2003, CANCER RES, V63, P5021
  • [8] Ferko A, 2003, Rozhl Chir, V82, P192
  • [9] Characterizing the role of MDM2 in diethylnitrosamine induced acute liver damage and development of pre-neoplastic lesions
    Finnberg, N
    Silins, I
    Stenius, U
    Högberg, J
    [J]. CARCINOGENESIS, 2004, 25 (01) : 113 - 122
  • [10] Attenuation of G1 checkpoint function by the non-genotoxic carcinogen phenobarbital
    Gonzales, AJ
    Christensen, JG
    Preston, RJ
    Goldsworthy, TL
    Tlsty, TD
    Fox, TR
    [J]. CARCINOGENESIS, 1998, 19 (07) : 1173 - 1183